经导管主动脉瓣植入术后肾素-血管紧张素抑制剂的疗效 - Suppr

Suppr

超能文献

Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.

作者信息

Hosseinpour Alireza, Gupta Rahul

机构信息

School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.

出版信息

Clin Cardiol. 2024 Feb;47(2):e24187. doi: 10.1002/clc.24187. Epub 2023 Nov 7.

DOI:10.1002/clc.24187

PMID:37933892

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10826235/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c88c/10826235/af3c795665f2/CLC-47-e24187-g001.jpg

相似文献

Outcomes of renin-angiotensin inhibitors following transcatheter aortic valve implantation.经导管主动脉瓣植入术后肾素-血管紧张素抑制剂的疗效

Clin Cardiol. 2024 Feb;47(2):e24187. doi: 10.1002/clc.24187. Epub 2023 Nov 7.

Transcatheter aortic valve implantation for low-risk aortic stenosis: are we ready?低风险主动脉瓣狭窄的经导管主动脉瓣植入术：我们准备好了吗？

Eur J Cardiothorac Surg. 2020 Mar 1;57(3):413-417. doi: 10.1093/ejcts/ezz372.

Moderate aortic stenosis: The next frontier of transcatheter aortic valve implantation?中度主动脉瓣狭窄：经导管主动脉瓣植入术的下一个前沿领域？

Arch Cardiovasc Dis. 2023 Jun-Jul;116(6-7):295-297. doi: 10.1016/j.acvd.2023.05.005. Epub 2023 Jun 9.

Valve-in-Valve Transcatheter Aortic Valve Replacement Following 2 Surgical Aortic Valve Replacements.在两次外科主动脉瓣置换术后进行经导管主动脉瓣置入术（瓣中瓣技术）

Circ Cardiovasc Interv. 2023 Nov;16(11):e013305. doi: 10.1161/CIRCINTERVENTIONS.123.013305. Epub 2023 Nov 21.

Editorial commentary: Selection of transcatheter heart valves: The plethora of device-specific, anatomic-specific and patient-specific aspects for optimal results in transcatheter aortic valve replacement.编辑评论：经导管心脏瓣膜的选择：在经导管主动脉瓣置换术中实现最佳效果所需考虑的大量特定器械、特定解剖结构和特定患者因素。

Trends Cardiovasc Med. 2022 Nov;32(8):523-524. doi: 10.1016/j.tcm.2021.10.003. Epub 2021 Oct 19.

Trends and outcomes in transcatheter aortic valve implantation: evolution of a revolution.经导管主动脉瓣植入术的趋势与结果：一场变革的演进

Acta Cardiol. 2022 Dec;77(10):984-985. doi: 10.1080/00015385.2022.2129181. Epub 2022 Nov 8.

Advancing Transcatheter Aortic Valve Replacement to the Frontiers of Lifetime Valve Management: Deliberations From the OBSERVANT II Trial.将经导管主动脉瓣置换术推进到终身瓣膜管理的前沿：来自OBSERVANT II试验的研讨

Circ Cardiovasc Interv. 2022 Dec;15(12):e012607. doi: 10.1161/CIRCINTERVENTIONS.122.012607. Epub 2022 Dec 9.

Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve.使用Navitor经导管心脏瓣膜进行经导管主动脉瓣置换术的技术考量

JACC Cardiovasc Interv. 2021 Oct 11;14(19):e259-e261. doi: 10.1016/j.jcin.2021.06.034. Epub 2021 Sep 15.

The 20-year "imaging saga" for transcatheter aortic valve implantation: A viewpoint.经导管主动脉瓣植入术的20年“影像传奇”：一种观点。

Arch Cardiovasc Dis. 2022 Apr;115(4):225-230. doi: 10.1016/j.acvd.2022.04.002. Epub 2022 Apr 26.

Commentary: Surgical aortic valve replacement after transcatheter aortic valve replacement: Is it time to reconsider the lifelong management?评论：经导管主动脉瓣置换术后的外科主动脉瓣置换术：是时候重新考虑终身管理了吗？

J Thorac Cardiovasc Surg. 2023 Jun;165(6):2024-2025. doi: 10.1016/j.jtcvs.2021.10.035. Epub 2021 Oct 29.

本文引用的文献

Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.经导管主动脉瓣置换术（TAVR）后，血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂（ACEI/ARB）和他汀类药物的开具模式与死亡率的关联：来自真实世界理赔数据的结果。

Am Heart J. 2023 Apr;258:27-37. doi: 10.1016/j.ahj.2022.12.012. Epub 2022 Dec 31.

The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysis.经导管主动脉瓣置换术后患者使用肾素-血管紧张素系统抑制剂的临床结局：一项系统评价和荟萃分析。

Front Cardiovasc Med. 2022 Aug 11;9:963731. doi: 10.3389/fcvm.2022.963731. eCollection 2022.

Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.血管紧张素转化酶抑制剂类型和剂量对经导管主动脉瓣植入术后生存的影响。

Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):815-824. doi: 10.1093/ehjcvp/pvac027.

Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后的最佳药物治疗。

Am J Cardiol. 2021 Feb 15;141:62-71. doi: 10.1016/j.amjcard.2020.11.010. Epub 2020 Nov 19.

Dose-Dependent Effect of Renin-Angiotensin System Blockade Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后肾素-血管紧张素系统阻断的剂量依赖性效应。

Can J Cardiol. 2021 Mar;37(3):443-449. doi: 10.1016/j.cjca.2020.08.014. Epub 2020 Aug 22.

Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.肾素-血管紧张素系统抑制剂对接受经导管主动脉瓣置换术的重度主动脉瓣狭窄患者临床结局的影响：来自PARTNER 2试验及注册研究的分析

Eur Heart J. 2020 Feb 21;41(8):943-954. doi: 10.1093/eurheartj/ehz769.

Renin-angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival.经导管主动脉瓣置换术（TAVR）后进行肾素-血管紧张素系统阻断可改善中期生存率。

J Cardiovasc Thorac Res. 2019;11(3):176-181. doi: 10.15171/jcvtr.2019.30. Epub 2019 Aug 13.

Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后肾素-血管紧张素系统抑制。

J Am Coll Cardiol. 2019 Aug 6;74(5):631-641. doi: 10.1016/j.jacc.2019.05.055.

Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.肾素-血管紧张素抑制剂治疗与经导管主动脉瓣置换术后患者死亡率和心力衰竭再入院的关系。

JAMA. 2018 Dec 4;320(21):2231-2241. doi: 10.1001/jama.2018.18077.

Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.经导管主动脉瓣植入术后肾素-血管紧张素系统阻断治疗。

Heart. 2018 Apr;104(8):644-651. doi: 10.1136/heartjnl-2017-311738. Epub 2017 Oct 6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验